Hrozencik DS - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.

Archer DF, Pinkerton JV, Guico-Pabia CJ, Hwang E, Cheng RF; Study 3353 Investigators. Archer DF, et al. Menopause. 2013 Jan;20(1):47-56. doi: 10.1097/gme.0b013e3182775fe9. Menopause. 2013. PMID: 23266840 Clinical Trial.

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.

Pinkerton JV, Constantine G, Hwang E, Cheng RF; Study 3353 Investigators. Pinkerton JV, et al. Menopause. 2013 Jan;20(1):28-37. doi: 10.1097/gme.0b013e31826421a8. Menopause. 2013. PMID: 23010882 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters